Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
News 16 January 2026 Wegovy to be listed on PBS The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended Wegovy (semaglutide) be subsidised through the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease and obesity. Diabetes Australia’s Group CEO... Continue Reading
News 10 November 2025 Families celebrate a day out at Luna Park ahead of World Diabetes Day Children living with type 1 diabetes and their families enjoyed a free day out at Luna Park in Sydney, at... Continue Reading
Media releases 13 October 2025 My Health Record upgrades improving integrated care Faster access to more health data on My Health Record will benefit Australians living with diabetes. The Australian Digital... Continue Reading
